![Daina Vanags](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karriereverlauf von Daina Vanags
Ehemalige bekannte Positionen von Daina Vanags
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Geschäftsführer | 19.10.2011 | 05.09.2012 |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 05.09.2012 | |
Präsident | 01.01.2004 | 05.09.2012 | |
INVION LIMITED | Geschäftsführer | 12.10.2011 | - |
Technik-/Wissenschafts-/F&E-Leiter | 12.10.2011 | - |
Statistik
International
Australien | 3 |
Operativ
Chief Operating Officer | 2 |
Chief Tech/Sci/R&D Officer | 2 |
President | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
INVION LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
CBio Ltd.
![]() CBio Ltd. BiotechnologyHealth Technology CBio Ltd. focuses on developing new generation products for the treatment of autoimmune and inflammatory diseases. It develops and commercializes treatments for autoimmune diseases. The company focuses and develops technologies on commercializing its proprietary drug, XToll for autoimmune and inflammatory diseases. It develops technologies for the treatment of autoimmune and inflammatory diseases. The company also engages in the business of research, product development and clinical trials of the therapeutic drug XToll and development of variants to the company's Cpn10 technology. CBio was founded by Steve P. Jones on October 11, 2000 and is headquartered at Brisbane, Australia. | Health Technology |
- Börse
- Insiders
- Daina Vanags
- Erfahrung